Biosynthesis of glycogen, the essential glucose (and hence energy) storage molecule in humans, animals and fungi 1 , is initiated by the glycosyltransferase enzyme, glycogenin (GYG). Deficiencies in glycogen formation cause neurodegenerative and metabolic disease [2] [3] [4] , and mouse knockout 5 and inherited human mutations 6 of GYG impair glycogen synthesis. GYG acts as a 'seed core' for the formation of the glycogen particle by catalysing its own stepwise autoglucosylation to form a covalently bound gluco-oligosaccharide chain at initiation site Tyr 195. Precise mechanistic studies have so far been prevented by an inability to access homogeneous glycoforms of this protein, which unusually acts as both catalyst and substrate.
. Although bespoke biosynthetically deficient expression host strains can generate 11 a glycan-free, starting form of GYG, this allows access to only one catalyst state (Supplementary Text). As a result, any possible '(sub)phases' subsequent to this starting state may be obscured if they follow faster kinetics. A lack of access to homogeneous GYG catalyst states therefore restricts our current understanding.
We reasoned that chemical construction of pure GYG in different glucosylation states might allow a strategy for direct, guided ('shunted') activation (and hence interrogation) of chosen intermediate states ( Fig. 1, Extended Data Figs. 1, 2a) . The unusual hybrid nature of these catalyst states-part-catalyst, part-substrate-suggested a convergent (tag-and-modify 12 ) construction process in which the desired (glycosyl acceptor) glycan moiety would be covalently attached in one step to key catalytic site 195 (Extended Data Fig. 1c) . We have previously demonstrated that Pd(0)-mediated C-C-bond-forming ligation is feasible and benign in certain biological contexts [13] [14] [15] [16] [17] . Pd-mediated approaches in biology have since been elegantly exploited by various groups [18] [19] [20] . However, GYG is a testing target biomolecule on which to apply this method. Not only is site 195 in the heart of the active site, but GYG is also metal-dependent, raising the possibility of inhibitory 'poisoning' cross-competition 21, 22 by Pd at the metal co-factor site. A suitable precursor GYG1 bearing a reactive 'tag' for Pd(0)-mediated C-C bond formation was generated via site-specific unnatural amino acid incorporation 14, 23, 24 , giving a variant in which the p-hydroxy group of the natural, wild-type (WT) tyrosine residue at site 195 was exchanged for an iodide moiety (OH → I, GYG-Tyr195 → GYGpIPhe195, Fig. 1 ). Characterization confirmed no deleterious effects on overall enzyme structure. The structure of GYG-Y195X, determined in both apo (2.2 Å) and Mn 2+ + UDP bound (2.4 Å) states (Supplementary Table 1 ; UDP, uridine diphosphate), revealed dimers that were highly superimposable on those in GYG-WT 10 (Extended Data Fig. 2c ). In the ligand-bound state, the pIPhe195 group from one monomer is clearly visible (Extended Data Fig. 2d , inset), located within a partially unwound helix that adopts a catalytically poised position equidistant from either active site of the dimer (Extended Data Fig. 2d, red) . Asymmetry at the dimer interface, consistent with previous unglucosylated GYG-WT structures 10 , suggested likely conformational flexibility needed as GYG transitions from unconjugated to differently glucosylated forms.
Studies on wild-type GYG (GYG-WT/GYG-Tyr195) revealed concentration-dependence of Pd inhibition and hence determination of essentially benign Pd concentrations that would successfully allow preservation of enzymatic activity (Extended Data Fig. 3 , Supplementary Note); other cross-coupling components had minimal effect. These conditions allowed successful Pd-mediated C(sp 2 )-C(sp 2 ) ligation of GYG-pIPhe195 to a variety of designed, systematically altered 'substrate templates' (Fig. 1, Extended Data Figs. 2a, 4) ; all bore nucleophilic, hydroxyl groups as possible reaction sites for autoglucosylation (readily prepared as their corresponding C(sp 2 ) boronic acid derivatives 1, see Supplementary Methods). Small amounts of side-products were also identified (Extended Data Fig. 5 ): for example, unreacted GYGpIPhe195 or species attributable to dehalogenation 17 using liquid chromatography-mass spectrometry (LC-MS) analysis and negative control studies (Supplementary Methods and Supplementary Text). Despite successful Pd-mediated ligation, 'simple' glycan-mimic templates (Extended Data Figs. 2a, 4) provided ineffective mimicry: irrespective of their systematically varied properties (orientation, length or pK a ), none led to activation of autoglucosylation. Activation of GYG requires therefore more than just an available hydroxyl nucleophile positioned Letter reSeArCH in the active site. However, for more complex substrate templates displaying glucosyl moieties inside GYG, not only did protein LC-MS analysis reveal successful C-C ligation but also concomitant activation ('switch on') and clear autoglucosylation activity in the resulting 'shunted' intermediate product GYG-Glc as well as the more advanced, chain-extended 'shunted' states GYG-Glc-Glc and GYG-Glc 6 (Fig. 2 , Supplementary Information). Side-products from cross-coupling (Extended Data Fig. 5 ) were inactive to autoglucosylation and thus did not interfere in the assay.
This chemically generated access to 'shunted' functionally active intermediate states of GYG along the glycogen biosynthetic pathway allowed us to uniquely probe and compare activity using LC-MS monitoring of the sugars attached over time (Fig. 2c, d , Extended Data Figs. 6, 7, Supplementary Methods). Immediately contrasting behaviours from different states were observed. For more extended GYG-Glc-Glc, two distinct glucosylation phases were apparent: rapid glucosylation from 2 until about 4-5 Glc total, then substantially slower catalysis thereafter (Fig. 2c, d) . Indeed, the initial step (GYGGlc-Glc → GYG-Glc-Glc-Glc) was extremely rapid; on-protein kinetic analyses conducted in replicate (see Supplementary Methods) revealed that about 90% of starting GYG-Glc-Glc was consumed within 20 s. In striking contrast, GYG-Glc exhibited a more gradual decline in glucosylation rate with increasing oligosaccharide length (Fig. 2c, d ), consistent with a substantially slower initiation subphase for GYG-Glc (GYG-Glc → GYG-Glc-Glc) that thus obscures the rapid phase immediately following (Extended Data Fig. 6d ). Taken together, these data suggested a triphasic mechanism, in which a rapid intermediate phase is flanked by slower initiation (<2 glucoses) and elongation (>4/5 glucoses) phases (Extended Data Fig. 6d) . Notably, only through the direct 'shunt' formation of intermediates (GYG-Glc, GYG-Glc-Glc, and so on) achieved through Pd-mediated ligation was unobscured analysis of each subphase made possible (Extended Data Fig. 7 ). Clear visualization of this kinetic profile was a consequence of our ability to both circumvent initial slow Tyr195 glucosylation and also probe discrete glucosylation states immediately after this. The presence of distinct (sub)phases is consistent with the proposed 10, 25, 26 existence of different glucosylation mechanisms for GYG.
Use of 'shunted' intermediates GYG-Glc, GYG-Glc-Glc and GYGGlc 6 allowed the determination of initial rates that gave apparent rate constants for each associated phase of k app = 0.016, 0.126 and 0.003 s , respectively (Extended Data Fig. 7b ). These were also compared directly with kinetics determined from analysis of wild-type GYG in unglucosylated form (GYG-WT-Glc0, Extended Data Fig. 7 ). As expected, the inability to access intermediate states for GYG-WT failed to reveal the distinct phases shown by our chemically 'shunted' system. Nonetheless, global values for turnover proved consistent; we now show that one consequence of the triphasic regime is an accumulation of glucosylation at the end of the fast phase 2 mechanism regime (lengths 5-6 Glc) going into the slower phase 3. Taken together, this confirmed quantitative mimicry at similar activity levels and highlighted the need for the chemical 'shunted' approach in revealing detailed mechanism.
Quantum mechanics/molecular mechanics (QM/MM) metadynamics 27, 28 simulations (see Supplementary Methods) allowed further insight through detailed reconstruction of the free-energy surface of reaction as a function of a few selected degrees of freedom (collective variables, CVs; Supplementary Methods). Michaelis complexes equivalent to GYG-GlcGlc → GYG-Glc-Glc-Glc (both in WT, GYG-WT-Glc3 → GYG-WTGlc4, and 'shunted' , GYG-Glc-Glc → GYG-Glc-Glc-Glc, form) were reconstructed from the structures determined here and of those in complex with UDP-Glc and cellotetraose 10 . Both wild-type and 'shunted' forms gave similar results (Extended Data Fig. 8 ), consistent with kinetic parameters. The free-energy surface revealed a short-lived intermediate (Extended Data Fig. 9 ) along the minimum free-energy pathway indicative of a front-face, 'S N i-like' reaction mechanism (see Supplementary Video) 29, 30 . The free-energy barrier of approximately 10 kcal mol ), suggesting potentially different rate-limiting processes. Thus, together our kinetic experimental and QM/MM data reveal unprecedentedly fast glycosyl-transfer for the second subphase of glycogen formation. The Michaelis complex (R′ in Extended Data Fig. 9b ) exhibits a near-perfect approach between the O4′-H acceptor bond and the C1-O P donor bond to assist the departure of UDP. The resulting very short C1···O4′ and H···O P distances (3.3 and 2.0 Å, respectively, compared with 3.2 and 2.5 Å in prior, representative systems 30 ) for formed bonds provide excellent stabilization of charge developed at the phosphate, together with proper orientation for forthcoming front-face nucleophilic attack of O4′ onto C1 of Glc. The acceptor O-H in GYG thus creates a direct hydrogen bond H···O P , unlike prior systems, resulting in a more stretched sugar-phosphate bond (C1-O P ) in GYG (1.58 Å compared to 1.51 Å; ref. 30 ) with a much lower associated bond energy (about 10 kcal mol ). To probe the selectivities of this multiphasic GYG mechanism, we next investigated the potential of GYG to use non-glucose sugar substrates 31 . The potential for GYG to use non-glucose acceptor sugar moieties has not been examined owing to the inability, until now, to directly access requisite intermediate enzyme states and to insert into those states non-glucose sugars. GYG-Glc and GYG-Glc-Glc generated by Pd-mediated ligation were capable of using the non-glucose donor sugar UDP-galactose with kinetic profiles essentially qualitatively similar to analogous autoglucosylation reactions (Fig. 3a) , thereby forming GYG-Glc-(Gal) n and GYG-Glc-Glc-(Gal) n . Notably, however, the third kinetic (sub)phase observed for autoglucosylation was curtailed for autogalactosylation (Extended Data Fig. 6 ). Shunted access to GYG bearing common non-glucose but naturally occurring mammalian monosaccharides d-galactose (GYG-Gal) and d-mannose (GYGMan) (Fig. 3b , Supplementary Information, using boronic acid reagents 1-Gal, 1-Man) revealed that both were capable of autoglucosylation to This GYG-pIPhe195 enzyme, which lacks a native glycosyl acceptor and thus cannot undergo glucosylation, represents a suitable substrate for Pdmediated Suzuki-Miyaura cross-coupling (second transformation) to a range of boronic acid sugar mimic templates, to generate potentially active enzyme species that mimic defined GYG glycoforms. In this way, inactive GYG-pIPhe195 might be activated through C-C bond-forming ligation allowing pre-determined, ' Letter reSeArCH form both GYG-Gal-(Glc) n and so on and GYG-Man-(Glc) n and so on (Fig. 3c) . Kinetic analyses of this non-glucose acceptor activity of GYG revealed glucosylation rates for GYG-Gal and GYG-Man that are initially lower as a consequence of a substantially slower initiation step/(sub)phase. In contrast to their plasticity towards glucosylation, the non-glucose enzyme states GYG-Gal and GYG-Man did not catalyse autogalactosylation to any substantial extent (Supplementary Table 12 ). Molecular dynamics (MD) simulations (Extended Data Fig. 9 ) suggested that the altered configurations of non-glucose sugars-for example, Gal in GYG-WT-Glc-Gal or UDP-Gal-necessitated slight reorientations but could be accommodated without substantially altering the interactions at the active site with key hydroxyl-binding residues. The result is that the distance of the putative nucleophile and GYG-Glc-Glc (middle row) are capable of using the unnatural donor UDP-galactose, as shown by LC-MS. Bottom row, kinetic profiles for overall galactosylation (left) and rate of initial galactosylation step (right). Data points represent mean averages of n = 3 independent replicate kinetic runs for both GYG-Glc and GYG-Glc-Glc galactosylation. Error bars are ±1 s.d. b, Generation of non-natural GYG glycosyl acceptors GYG-Gal and GYG-Man (bottom and top respectively), as shown by LC-MS. Similar results were obtained for at least three independent repeats. c, Autoglucosylation activity of GYG-Man (top row) and GYG-Gal (middle row) compared to GYG-Glc, as shown by LC-MS. Bottom row, kinetic profiles analogous to those in a, overall glucosylation (left) and rate of initial glucosylation step (right) are shown. Data points represent mean averages of n independent replicate kinetic runs; n = 4 (GYG-Glc) and n = 3 (GYG-Gal, GYG-Man). Error bars are ±1 s.d. In all cases, nonglycosylated side-products present show no activity in the assay. a, Pd-mediated C-C bond-forming ligation of glucose-derived boronic acid 1-Glc to GYG-Y195X generates in good yield the homogeneous glycoform GYG-Glc, which exhibits catalytic activity, as shown by LC-MS analysis. Similar results were obtained for at least four independent repeats. In all cases, non-glucosylated side-products present show no activity in the assay. b, Cross-coupling to 1-Glc-Glc instead enables direct, 'shunted' access to a further catalytic intermediate of GYG-Glc, GYG-Glc-Glc, which also proved catalytically active, as also shown by LC-MS. Similar results were obtained for at least five independent repeats. In all cases, non-glucosylated side-products present show no activity in the assay. c, d, Kinetic profiles of overall glucosylation (c) and the initial glucosylation step as monitored through consumption of starting enzyme (d and inset) for GYG-Glc and GYG-Glc-Glc. The glucosylation levels and abundance of the starting enzyme were determined through LC-MS analysis (see also Extended Data Fig. 6 and Supplementary Methods).
Whereas GYG-Glc-Glc exhibits a marked 'fast → slow' biphasic profile, these same phases, while necessarily present for GYG-Glc, are not visible, being instead obscured by a slower initiation step. For both c and d, data points represent mean averages of n independent replicate kinetic runs; n = 4 (GYG-Glc) and n = 5 (GYG-Glc-Glc 4 | Natural and unnatural pathways of GYG catalysis further delineate a triphasic mechanism and reveal a possible proof-reading step. a, Motion of Tyr195 to accommodate acceptor substrates of various lengths and conformations (intra-and inter-monomeric). Results were obtained from MD simulations for each Michaelis complex. Acceptor sugar units have been omitted for clarity. The orange loop corresponds to the acceptor arm of the same subunit of the displayed active site (that is, intra), whereas the white loop is the acceptor arm of the opposite subunit (inter). The tyrosine residue represented as transparent indicates an unstable conformation due to steric hindrance with the 'blocking loop' coloured in blue. Notice that the tyrosine residue recoils one position for each sugar that is attached to it. Hydrogen atoms and acceptor glucose units have been omitted for clarity. b, Comparison of the natural autoglucosylation pathway (and the unnatural autogalactosylation pathway for various GYG substrates) reveals that, while the slower first and third phases (which we speculate operate through inter-monomer multimer modes; see right hand column schematic) display limited GalGal transfer, this reaction readily proceeds throughout the fast second phase (which we speculate is intra-monomer). The consequent absence of a third phase for autogalactosylation may function as a 'refining' step, preventing incorporation of poly-Gal oligosaccharides into glycogen and thus preventing accumulation of misformed, potentially toxic, glycogen particles. Phase characteristics are summarized on the left. Letter reSeArCH (OH-4) from the electrophilic anomeric carbon (in UDP-Gal or UDPGlc, respectively) is not greatly perturbed (O···C1 change <0.5 Å) and O-C bond formation can thus evolve essentially 'normally' despite such changes, reflecting this experimentally observed plasticity. Taken together, distinct mechanistic phases of GYG (Fig. 4 ) are therefore defined not only by different rates but also different donor/acceptor tolerance. Whereas the second, rapid phase (2 to 4/5 sugars) readily tolerates Gal-to-Gal transfer throughout (species with up to 5 sugars are quickly generated from GYG-Glc-Glc), the first and third phases show similarities in being linked by not only their slower glucosylation rates but also their apparent lower tolerance of nonglucose in both acceptor and donor at the same time. A plastic and rapid second phase is thus seemingly preceded by a slower step that can nonetheless be primed with unnatural sugars-immediately surprising given the presumed specific role of glycogen as a glucosestorage polymer-and is followed by a slower and much more selective third phase. Together these three phases appear to allow 'priming' with non-glucose sugars in the first phase (for example, Gal, Man) followed by more rapid and more plastic 'extension' in the second phase (with either UDP-Glc or UDP-Gal) before a third 'refining' phase that ensures use of only glucose in the more extended portions of the inner core of glycogen.
From data gathered here and earlier 10 , we speculate that these phases may reflect, in part, transitions between intra-monomeric and inter-monomeric modes of glucosylation within the active GYG protein dimer. From our structure of GYG-pIPhe195, we see that the anchor point for the oligosaccharide chain of glycogen is essentially equidistant from the two active sites in GYG dimer. MD simulations (Extended Data Fig. 8 ) with GYG bearing Glc-oligomer chains of different lengths (GYG-WT-Glc n , n = 0-5) and conformations (intra-/inter-monomeric) suggest that the first glucosylation steps (n = 0, 1) are preferentially inter-monomeric. A 'blocking loop' in between the acceptor arm and the active site of the same subunit hampers intra-monomeric conformations. In contrast, sugar chains of subsequent steps (n = 2, 3) circumvent the blocking loop, allowing intramonomeric conformations. A key positioning residue GYG-Asp 125 binds the nucleophilic acceptor Glc terminus, allowing equilibration into a productive Michaelis complex and guides the OH-4 to the donor site from the α face of UDP-Glc, ready for the front-face attack (optimal for intermediate levels of GYG glucosylation). Key to this process is a striking flexibility of GYG-Tyr195, which steadily recoils step-by-step by the distance of one sugar ring to accommodate acceptor Glc n chains of increasing lengths (Fig. 4) .
Together these data suggest a first inter-monomer phase in which the nascent oligosaccharide chain is of insufficient length to easily provide the right orientation to be processed by the active site but can eventually equilibrate ('hooked' into place by Asp 125) to a productive Michaelis complex owing to flexibility of Tyr195. In the second phase, sufficient flexibility of the oligosaccharide chain allows correct orientation and a rapid intra-monomer extension, yet with low selectivity. Finally, in the third 'refining' phase, extension of the nascent oligosaccharide chain past the active site of its own protein monomer requires extension by the active site of another monomer in a much more closely linked dimer, which requires careful alignment of donor substrate (UDP-Glc only) recruitment with binding of the extending chain. Eventually, this chain too processes past the point of the second active site and GYG's activity ceases at a longer chain length of more than 12 Glc units. This presents a Glc-terminated core-glycan particle ready for elaboration by glycogen synthase (GYS) and glycogen branching enzyme (GBE), respectively (Extended Data Fig. 1 ) 1, 32 . The plasticity of GYG raises the question of whether nonglucose sugars can ever be incorporated into mature glycogen particles. Whereas natural incorporation of mannose from its most abundant nucleotide GDP-mannose is not feasible owing to the known specificity of GYG for pyrimidine nucleotide sugar donors 32 , UDP-Gal is readily available in vivo. In this light, the limited final kinetic phase for autogalactosylation is consistent with a 'refining' mechanism that prevents misformed glycogen particles due to, for example, poly-Gal incorporation (Fig. 4) . At the same time, GYG's ability to utilize UDP-Gal in earlier phases may facilitate early glycogenesis during times in which UDP-Glc supplies are scarce. This suggests that the core of glycogen can carry priming glycans that may be non-glucose in nature. Our work here also highlights that while non-glucose sugars might serve this role, other simpler, hydroxyl-only templates fail. This, in turn, suggests that this core region does not serve as an energy storage polymer (since it would release incorrect sugars for metabolism) but instead acts to anchor glycogen to the glycogenin core protein. Together, these three phases-primeextend-refine-therefore appear to represent a mechanistic solution to the delicate evolutionary balance between the difficult-to-achieve need to anchor glucose-polymer to a protein with the need to ensure precise glucose-only particle formation at its outer regions.
The chemical ligation approach used here has shown that, whereas natural C-O Tyr195-to-glucose linkages cannot be accessed via any current chemical modification approach (Extended Data Fig. 10 ), Pd-mediated formation of an irreversible C-C bond can yield sufficiently similar motifs to allow functional mimicry of GYG in glycogenesis. They reveal that GYG's catalytic activity does indeed vary through these intermediate states and highlight how this 'selfmodulation' seems to be exploited by nature in three phases with different function. We anticipate that this methodology may ultimately be expanded to access a wider range of precise glycogen structures, enabling study of other glucosylation and associated processing steps that will shine further light on the expanding number of glycogenassociated diseases 1, 2, 4, 33 . More broadly, the demonstration of successful mimicry that we have achieved here by using chemistry to covalently and directly 'bolt in' a key residue alteration to create an intermediate catalytic state highlights that new protein chemistries are becoming accurate and subtle enough to allow precise (for example, 'shunt') mechanistic experiments that would be difficult through classical biochemical means. Although strategies for chemical rescue of enzymes via unmasking of caged natural residues have been elegantly explored 19, 34, 35 , to our knowledge these experiments mark rare application of Pd-mediated C-C-bond-forming ligation as a mode of chemical enzyme activation. It suggests that such ligation-dependent activation (here using catalytic metal Pd(0) as a 'switch') could be a powerful tool not only in the study of mechanism but even potentially in the future 'rescue' of deficient enzymes.
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